
Sutro Biopharma Inc (STRO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 4.914 | -35.781 | -26.765 | -29.377 | -11.673 | -28.698 | -31.858 | -24.335 |
Return on Equity (%) | -3.745 | 19.698 | -313.4 | -48.615 | -14.949 | -36.105 | -50.767 | -58.246 |
Return on Invested Capital (%) | -2.972 | 19.086 | -255.512 | -48.704 | -32.146 | -35.788 | -63.457 | -60.284 |
Operating Margin (%) | 2.849 | -36.868 | -87.701 | -120.259 | -65.659 | -165.483 | -167.264 | -50.361 |
Net Profit Margin (%) | 2.849 | -38.051 | -91.926 | -130.438 | -75.202 | -170.553 | -175.89 | -69.467 |
Book Value Per Share | -201.108 | -234.411 | 5.757 | 4.233 | 7.258 | 5.452 | 3.775 | 2.455 |
Earnings Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.073 | -1.752 |
Cash Per Share | 25.648 | 47.355 | 5.484 | 0.215 | 4.506 | 0.657 | 0.822 | 1.136 |
Working Capital Per Share | -1.091 | -13.606 | 7.595 | 4.139 | 7.619 | 3.816 | 4.984 | 5.378 |
Operating Profit Per Share | 132.148 | 111.271 | 1.682 | 1.85 | 0.934 | 1.336 | 1.179 | 2.522 |
EBIT Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.03 | -1.454 |
EBITDA Per Share | 3.765 | -42.34 | -1.546 | -2.413 | -0.702 | -2.278 | -2.03 | -1.454 |
Free Cash Flow Per Share | 0.96 | -45.94 | -1.676 | -2.469 | -0.64 | -2.052 | -2.035 | -1.793 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 452k | 465k | 22,85M | 23,1M | 45,75M | 46,33M | 57,5M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 57,5M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -368.226 | N/A | N/A | N/A | -430.504 | N/A | N/A |
Net Profit Margin (%) | N/A | -394.903 | N/A | N/A | N/A | -447.517 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 78,11M |
Ratio cours/bénéfice | -0,71 |
Ratio prix/ventes | 0,49 |
Ratio prix/liquidités | 1,09 |
Ratio prix/valeur comptable | 0,5 |
Rendement de dividende | - |
Actions en circulation | 83,78M |
Volume moyen (1 semaine) | 4,91M |
Volume moyen (1 mois) | 1,87M |
Variation sur 52 semaines | -78,11% |
Plus haut sur 52 semaines | 6,13 |
Plus bas sur 52 semaines | 0,7621 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales